Published in World J Gastrointest Oncol on September 15, 2010
Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer (2013) 1.06
Helicobacter pylori therapy: Present and future. World J Gastrointest Pharmacol Ther (2012) 0.97
Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol (2012) 0.97
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut (2014) 0.95
Helicobacter pylori: A Beneficial Gastric Pathogen? Front Med (Lausanne) (2014) 0.92
Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"? World J Gastroenterol (2013) 0.84
Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol (2015) 0.83
Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Br J Cancer (2015) 0.81
Withaferin A Inhibits Helicobacter pylori-induced Production of IL-1β in Dendritic Cells by Regulating NF-κB and NLRP3 Inflammasome Activation. Immune Netw (2015) 0.79
Role of Sonic Hedgehog signaling during progression from inflammation to cancer in the stomach. World J Gastrointest Pathophysiol (2011) 0.78
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma. BMC Clin Pathol (2016) 0.77
Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders. World J Gastroenterol (2013) 0.77
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomark Res (2016) 0.76
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Helicobacter pylori infection. N Engl J Med (2002) 14.81
Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser (2003) 14.60
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA (2004) 6.96
E-cadherin germline mutations in familial gastric cancer. Nature (1998) 6.72
Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet (2004) 6.35
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science (2001) 5.49
Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology (1998) 5.15
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut (2001) 4.97
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer (1993) 3.86
Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition (1999) 3.84
Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83
Carcinogenesis of Helicobacter pylori. Gastroenterology (2007) 3.63
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol (2009) 2.89
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J (2000) 2.08
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem (2004) 2.01
Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol (1996) 1.99
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (2006) 1.98
Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control (2008) 1.96
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol (1999) 1.76
Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol (2007) 1.72
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
Treatment of Helicobacter pylori infection. BMJ (2008) 1.56
Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer (2002) 1.51
Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol (2005) 1.48
Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer (2002) 1.43
Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev (1994) 1.42
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg (2005) 1.39
Family history and the risk of gastric cancer. Br J Cancer (2009) 1.27
The time to eradicate gastric cancer is now. Gut (2005) 1.22
Helicobacter pylori CagA -- a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer (2006) 1.21
Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer (2000) 1.18
Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest (2008) 1.14
Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol (2004) 1.13
Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer (2008) 1.09
Animal models of stomach carcinogenesis. Toxicol Pathol (2007) 1.04
Oxidative stress and antioxidants in intestinal disease. Dig Dis (1998) 1.03
Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control (2008) 1.00
Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates. Gastroenterology (2009) 1.00
Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer (2006) 0.98
Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans. Eur J Cancer Prev (1998) 0.96
Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J Gastroenterol (2003) 0.88
Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathol Res Pract (2008) 0.87
Cellular origin of gastric cancer. Ann N Y Acad Sci (2008) 0.86
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci (2003) 0.85
Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA. World J Gastroenterol (2005) 0.83
Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer. Am J Gastroenterol (2009) 0.77
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med (2007) 3.26
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12
Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials. Am J Gastroenterol (2009) 2.84
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study. Gut (2006) 2.56
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc (2009) 1.69
Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol (2009) 1.58
Treatment of Helicobacter pylori infection. BMJ (2008) 1.56
Investigating dyspepsia. BMJ (2008) 1.41
Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society. World J Emerg Surg (2010) 1.39
Epidemiology of Helicobacter pylori infection. Helicobacter (2014) 1.26
Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res (2003) 1.25
Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res (2003) 1.20
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget (2011) 1.11
Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology (2010) 1.06
High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. Clin Cancer Res (2005) 1.04
Diagnosis and management of gastric antral vascular ectasia. World J Gastrointest Endosc (2013) 1.01
Side-viewing endoscope for colonic self-expandable metal stenting in patients with malignant colonic obstruction. Eur J Gastroenterol Hepatol (2009) 0.96
Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clin Gastroenterol Hepatol (2009) 0.95
13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter (2005) 0.95
Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle (2012) 0.91
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc (2013) 0.91
A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter (2002) 0.90
Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative colitis patients and healthy subjects. Dig Dis Sci (2011) 0.89
Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol (2012) 0.88
Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol (2009) 0.87
Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best Pract Res Clin Gastroenterol (2011) 0.85
Phytochemicals and colorectal cancer prevention--myth or reality? Nat Rev Gastroenterol Hepatol (2011) 0.84
Single session versus separate session endoscopic ultrasonography plus endoscopic retrograde cholangiography in patients with low to moderate risk for choledocholithiasis. J Gastroenterol Hepatol (2009) 0.84
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2009) 0.83
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer (2014) 0.83
Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases. Int J Surg Pathol (2013) 0.83
Inter-centre variability of the adenoma detection rate: a prospective, multicentre study. Dig Liver Dis (2013) 0.82
Clinical application of faecal calprotectin in ulcerative colitis patients. Eur J Gastroenterol Hepatol (2015) 0.79
What is the best salvage therapy for patients with Helicobacter pylori infection? Nat Clin Pract Gastroenterol Hepatol (2008) 0.79
Gastric cancer: who is at risk? Dig Dis (2004) 0.79
Colorectal stenting as a bridge to surgery reduces morbidity and mortality in left-sided malignant obstruction: a predictive risk score-based comparative study. Dig Liver Dis (2012) 0.78
Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer. Am J Gastroenterol (2009) 0.77
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014. J Clin Gastroenterol (2015) 0.76
Treatment with telbivudine for fulminant hepatitis B. J Dig Dis (2013) 0.75
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions. Am J Gastroenterol (2010) 0.75
Was it really an "ugly" meta-analysis? Am J Gastroenterol (2009) 0.75
The role of genomic instabilities in affecting treatment responses of colorectal cancer. Dig Dis (2002) 0.75
[The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances]. Recenti Prog Med (2010) 0.75
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication. Cochrane Database Syst Rev (2016) 0.75
Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian survey. Liver Transpl (2017) 0.75
Antioxidant treatment for acute pancreatitis. Recent Pat Inflamm Allergy Drug Discov (2014) 0.75
The role of obesity in gastroesophageal reflux disease and Barrett's esophagus. Dig Dis (2012) 0.75
Chemoprevention in colorectal neoplasias: what is practical and feasible? Dig Dis (2002) 0.75